Takara Bio

Takara Bio ROE

Delisted

The Return on Equity (ROE) of Takara Bio (4974.T) as of Oct 27, 2026 is 0.90 %. In the previous year, Return on Equity (ROE) was 1.33 % — a change of -32.03% (lower).

ROE

0.90 %

YoY

-32.03%

Last updated:

In 2025, Takara Bio's return on equity (ROE) was 0.90 %, a -32.03% increase from the 1.33 % ROE in the previous year.

The Takara Bio ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
3.78 JPY
Jan 1, 2019
5.71 JPY
Jan 1, 2020
5.74 JPY
Jan 1, 2021
12.87 JPY
Jan 1, 2022
20.70 JPY
Jan 1, 2023
14.27 JPY
Jan 1, 2024
1.33 JPY
Jan 1, 2025
0.90 JPY
The Takara Bio ROE history
YEARROEYoY
0.90 %-32.03%
1.33 %-90.70%
14.27 %-31.08%
20.70 %+60.87%
12.87 %+124.09%
5.74 %+0.53%
5.71 %+51.34%
3.78 %+67.21%
2.26 %+1.56%
2.22 %+37.45%
1.62 %-37.21%
2.58 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Takara Bio Stock analysis

What does Takara Bio do? Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.

ROE Details

Decoding Takara Bio's Return on Equity (ROE)

Takara Bio's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Takara Bio's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Takara Bio's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Takara Bio’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Takara Bio stock

Return on Equity (ROE) of Takara Bio is 0.90 % in 2025.

Return on Equity (ROE) of Takara Bio changed from 1.33 % to 0.90 %, representing a -32.03% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Takara Bio since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Takara Bio with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Takara Bio

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Takara Bio